14 day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: a multicentre, non-inferiority, randomized trial | Zendy

JyhMing Liou | Zendy; ChiehChang Chen | Zendy; YuJen Fang | Zendy; PoYueh Chen | Zendy; Chi-Yang Chang | Zendy; ChuKuang Chou | Zendy; MeiJyh Chen | Zendy; ChengHao Tseng | Zendy; JiYuh Lee | Zendy; TsungHua Yang | Zendy; MinChin Chiu | Zendy; Jian-Jyun Yu | Zendy; ChiaChi Kuo | Zendy; JiingChyuan Luo | Zendy; WenFeng Hsu | Zendy; Wenhao Hu | Zendy; MinHorn Tsai | Zendy; JawTown Lin | Zendy; ChiaTung Shun | Zendy; Gary Twu | Zendy; Lee Yi-Chia | Zendy; MingJong Bair | Zendy; Ming-Shiang Wu | Zendy; ChunYing Wu | Zendy; Jeng–Yih Wu | Zendy; ChingChow Chen | Zendy; ChunHung Lin | Zendy; Yu-Ren Fang | Zendy; TsuYao Cheng | Zendy; PingHuei Tseng | Zendy; HanMo Chiu | Zendy; ChunChao Chang | Zendy; Chien-Chun Yu | Zendy; Yen-Nien Chen | Zendy; ChiMing Tai | Zendy; ChingTai Lee | Zendy; WenLun Wang | Zendy; Wen-Shiung Chang | Zendy

Open Access

14 day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: a multicentre, non-inferiority, randomized trial

Author(s) -

JyhMing Liou,

ChiehChang Chen,

YuJen Fang,

PoYueh Chen,

Chi-Yang Chang,

ChuKuang Chou,

MeiJyh Chen,

ChengHao Tseng,

JiYuh Lee,

TsungHua Yang,

MinChin Chiu,

Jian-Jyun Yu,

ChiaChi Kuo,

JiingChyuan Luo,

WenFeng Hsu,

Wenhao Hu,

MinHorn Tsai,

JawTown Lin,

ChiaTung Shun,

Gary Twu,

Lee Yi-Chia,

MingJong Bair,

Ming-Shiang Wu,

ChunYing Wu,

Jeng–Yih Wu,

ChingChow Chen,

ChunHung Lin,

Yu-Ren Fang,

TsuYao Cheng,

PingHuei Tseng,

HanMo Chiu,

ChunChao Chang,

Chien-Chun Yu,

Yen-Nien Chen,

ChiMing Tai,

ChingTai Lee,

WenLun Wang,

Wen-Shiung Chang

Publication year - 2018

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dky183

Subject(s) - esomeprazole , medicine , helicobacter pylori , randomized controlled trial , gastroenterology , second line therapy , chemotherapy

Whether extending the treatment length and the use of high-dose esomeprazole may optimize the efficacy of Helicobacter pylori eradication remains unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research